Jazdzewski Krystian, Murray Elizabeth L, Franssila Kaarle, Jarzab Barbara, Schoenberg Daniel R, de la Chapelle Albert
Human Cancer Genetics Program, Comprehensive Cancer Center, Ohio State University, 850 Biomedical Research Tower, 460 West 12th Avenue, Columbus, OH 43210, USA.
Proc Natl Acad Sci U S A. 2008 May 20;105(20):7269-74. doi: 10.1073/pnas.0802682105. Epub 2008 May 12.
Although papillary thyroid carcinoma (PTC) displays strong heritability, no predisposing germ-line mutations have been found. We show that a common G/C polymorphism (rs2910164) within the pre-miR-146a sequence reduced the amount of pre- and mature miR-146a from the C allele 1.9- and 1.8-fold, respectively, compared with the G allele. This is matched by a similar decrease in the amount of each pre-miR generated from the corresponding pri-miR-146a in an in vitro processing reaction. The C allele also interfered with the binding of a nuclear factor to pre-miR-146a. The reduction in miR-146a led to less efficient inhibition of target genes involved in the Toll-like receptor and cytokine signaling pathway (TRAF6, IRAK1), and PTC1 (also known as CCDC6 or H4), a gene frequently rearranged with RET proto-oncogene in PTC. In an association study of 608 PTC patients and 901 controls, we found marked differences in genotype distribution of rs2910164 (P = 0.000002), the GC heterozygous state being associated with an increased risk of acquiring PTC (odds ratio = 1.62, P = 0.000007), and both homozygous states protective with odds ratio = 0.42 for the CC genotype (P = 0.003) and odds ratio = 0.69 for the GG genotype (P = 0.0006). Moreover, 4.7% of tumors had undergone somatic mutations of the SNP sequence. Thus, our data suggest that a common polymorphism in pre-miR-146a affects the miR expression, contributes to the genetic predisposition to PTC, and plays a role in the tumorigenesis through somatic mutation. Preliminary evidence suggests that these effects are mediated through target genes whose expression is affected by the SNP status.
尽管甲状腺乳头状癌(PTC)具有很强的遗传性,但尚未发现有易感性的种系突变。我们发现,pre-miR-146a序列中的一个常见G/C多态性(rs2910164),与G等位基因相比,C等位基因使pre-miR-146a和成熟miR-146a的量分别减少了1.9倍和1.8倍。在体外加工反应中,从相应的pri-miR-146a产生的每种pre-miR的量也有类似程度的减少。C等位基因还干扰了一种核因子与pre-miR-146a的结合。miR-146a的减少导致对Toll样受体和细胞因子信号通路(TRAF6、IRAK1)以及PTC1(也称为CCDC6或H4)相关靶基因的抑制效率降低,PTC1基因在PTC中经常与RET原癌基因重排。在一项对608例PTC患者和901例对照的关联研究中,我们发现rs2910164的基因型分布存在显著差异(P = 0.000002),GC杂合状态与患PTC的风险增加相关(优势比 = 1.62,P = 0.000007),两种纯合状态均具有保护作用,CC基因型的优势比 = 0.42(P = 0.003),GG基因型的优势比 = 0.69(P = 0.0006)。此外,4.7%的肿瘤发生了该SNP序列的体细胞突变。因此,我们的数据表明,pre-miR-146a中的常见多态性会影响miR的表达,促成PTC的遗传易感性,并通过体细胞突变在肿瘤发生中发挥作用。初步证据表明,这些效应是通过其表达受SNP状态影响的靶基因介导的。